Leading the way to safer medication
 Crosscheck  Recommender

Aripiprazole

Description

It has been proposed that aripiprazole’s efficacy in schizophrenia and Bipolar I Disorder is mediated through a combination of partial agonism at dopamine D2 and serotonin 5-HT1A receptors and antagonism of serotonin 5-HT2A receptors.

ATC Classification

Code
Title
Category
N05AX12
Aripiprazole
N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics

Trade names

Trade name
Countries

Spain

Australia Austria Canada Cyprus France

Australia

Spain

Spain

Cyprus

Austria

United States

Spain

Cyprus

United Kingdom

Spain

Cyprus

Cyprus

Australia

Spain

Cyprus Spain

Product Monographs

Monograph
Type
Country
ABILIFY Solution for injection
MPI, EU: SmPC
ABILIFY Tablet
MPI, EU: SmPC